Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association.

Front Oncol

Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS CROB), Rionero in Vulture, Italy.

Published: December 2022

A case of concomitant hairy cell leukemia (HCL) and chronic lymphocytic leukemia (CLL) in a 50- year-old man was reported. Flow cytometry and droplet digital PCR (ddPCR) were used to detect the B-Raf proto-oncogene (BRAF) V600E mutation. The HCL population was the predominant component. The patient was first treated with cladribine and then with rituximab and achieved HCL partial remission. Importantly, the high sensitivity of our flow cytometric approach allowed the detection of a small population "P3," in addition to the typical HCL and CLL clones. The P3 clone changed over time, from an HCL-like to a CLL-like immunophenotype. This case is added to the few other cases of synchronous HCL and CLL already reported in the literature and underlines the importance of analyzing chronic lymphoproliferative disorders by highly sensitive diagnostic techniques, like the multicolor flow cytometry and ddPCR, to evaluate the possible association between HCL and CLL at diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760757PMC
http://dx.doi.org/10.3389/fonc.2022.1069977DOI Listing

Publication Analysis

Top Keywords

hcl cll
12
hairy cell
8
cell leukemia
8
chronic lymphocytic
8
lymphocytic leukemia
8
flow cytometry
8
hcl
6
case report
4
report hematologic
4
hematologic malignancies
4

Similar Publications

Background: Clonal mature B-cell lymphoproliferative disorders (B-LPDs) are a heterogeneous group of neoplasia characterized by the proliferation of mature B lymphocytes in the peripheral blood, bone marrow and/or lymphoid tissues. B-LPDs classification into different subtypes and their diagnosis is based on a multiparametric approach. However, accurate diagnosis may be challenging, especially in cases of ambiguous interpretation.

View Article and Find Full Text PDF

Introduction: B-cell lymphomas with a low degree of malignancy represent a heterogeneous group of diseases, that evolve slowly, but present particularities in terms of long-term survival.

Methods: We investigated the impact of anemia from the time of diagnosis in 249 patients with malignant B-cell lymphomas, diagnosed between January 2011 and December 2015, in the Hematology Department of the Sibiu County Emergency Hospital, Romania.

Results: We included 126 (50.

View Article and Find Full Text PDF

Hairy cell leukemia (HCL) and HCL-like disorders have to be distinguished because of their different biology and treatment response. Thus, we conducted a retrospective study on patients with HCL and hairy cell leukemia variant (HCLv) to assess diagnostic algorithms and treatment outcomes in a real-world setting. We analyzed 225 HCL and 26 HCLv patients with median follow-up of 67.

View Article and Find Full Text PDF

Broadening the horizon: potential applications of CAR-T cells beyond current indications.

Front Immunol

December 2023

Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Eppendorf, Hamburg, Germany.

Article Synopsis
  • Engineering immune cells, particularly CAR-T-cell therapies, has advanced significantly in treating hematological malignancies like acute lymphoblastic leukemia (B-ALL) and multiple myeloma, improving outcomes for patients with previously poor prognoses.
  • This review covers current research and innovations in CAR-T-cell therapy for various blood cancers, highlighting strategies applied across different diseases and identifying both common and unique treatment challenges.
  • It also discusses the limitations of CAR-T-cell therapy, including issues with the tumor microenvironment and adverse effects, and hints at future advancements such as artificial intelligence in CAR-T-cell engineering.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!